Pain is a huge burden on society, impacting not only patients but their families, friends and colleagues. There has been limited success in discovering new treatments for pain. Many conditions have no standard of care and, in cases where they do exist, they have limited efficacy. We want to change this.
We aim to deliver major therapeutic advances, by treating
patients with a high burden of disease, offering clear benefits
for patients and sound health economics for society. Our
exciting R&D pipeline includes several new drug candidates
and technologies to improve patients’ lives.